In an era where technology is reshaping healthcare, ophthalmology is experiencing a paradigm shift with artificial intelligence (AI)-driven advancements in vision correction. The latest milestone in t ...
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...
20h
News-Medical.Net on MSNNovel cyclic peptide antagonist can be a promising therapeutic approach for MASHThe farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.
B. Riley analyst Mayank Mamtani lowered the firm’s price target on Lineage Cell Therapeutics (LCTX) to $3 from $4 and keeps a Buy rating on the ...
Poland: A recent simulation study published in Scientific Reports revealed that individuals with asthma and chronic ...
6d
HealthDay on MSNCommon Vaginal Infection Should Be Treated as an STI, Study SaysA common vaginal infection that affects nearly 1 in 3 women worldwide should be reclassified as a sexually transmitte ...
Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...
Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results